AstraZeneca just announced results from its US-based trial. It found the vaccine to be 79% effective and safe for use, despite recent concerns around reports of...
Ocugen (OCGN) has been one of 2021’s biggest and unlikeliest success stories. The eye disease specialist has shifted its focus to getting another Covid-19 vaccine to market.\
Scientists are exploring several possibilities that might explain at least 18 reports of extremely rare blood clots in the brain that occurred in individuals in the...
Top EU Regulator Insists AstraZeneca Jab Is Safe While 24 Countries Have Banned It During a press conference on Tuesday, Europe's top medical regulator, the European...
Norway Investigates Whether AstraZeneca Vaccine Caused Deadly Blood Clots Update (1124ET): As the first AstraZeneca shots arrive in South America via the WHO's Covax program, the...
With EU countries breaking ranks in order to get access to the Russian Sputnik V COVID-19 vaccine, the EMA was forced into starting rolling review of...
In this roundtable discussion, four experts from academia and industry met to discuss challenges in refining and scaling up AAV production pipelines to meet the increasing...
How Does The J&J Vaccine Compare To Other COVID Vaccines? 4 Questions Answered Authored by Yves Smith via NakedCapitalism.com, We are running this post for one...
The FDA has approved emergency use of a third COVID-19 vaccine from Johnson & Johnson’s Janssen Biotech unit, The post FDA clears third emergency COVID-19 vaccine...
Friday the FDA Advisory Panel voted unanimously (22-0) to endorse the (one-shot, no mRNA) J&J.
A panel of expert advisers to the U.S. Food and Drug Administration began a meeting to discuss Johnson & Johnson’s one-dose COVID-19 vaccine on Friday, setting...
The Johnson & Johnson vaccine is different from the Moderna and Pfizer vaccines in a few important ways that could make it a huge help to...
Altimmune is among the biotechs trying to find more convenient delivery alternatives for COVID-19 vaccines
A transcript of The Conversation Weekly podcast episode #3.
J&J said its EUA will be based on topline efficacy and safety data from the nearly 44,000-patient Phase III ENSEMBLE trial
Johnson & Johnson’s Janssen unit has filed its single dose COVID-19 vaccine candidate with the FDA, asking for The post J&J asks FDA for emergency clearance...
Britain launched a trial to assess the immune responses generated if doses of the Covid-19 vaccines from Pfizer Inc. and AstraZeneca Plc are combined in a...
Both vaccines appear to reduce the risk of developing COVID-19, and so could be approved later this year.
Russia's "Sputnik V" Vaccine 92% Effective Against "Symptomatic" COVID Cases As it turns out, the Kremlin wasn't embellishing when it first said its COVID vaccine, developed...
Vaccines that use harmless viruses as a delivery mechanism are vulnerable to being attacked by our immune system – but experimenting with how they are given...
Vaccines that use harmless viruses as a delivery mechanism are vulnerable to being attacked by our immune system – but experimenting with how they are given...
Johnson & Johnson published interim Phase I/IIa data in the New England Journal of Medicine showing the company's single-dose Covid-19 vaccine candidate created an immune response
US stocks are modestly higher as investors await details of President-elect Biden’s multi-trillion-dollar stimulus package, further clues if some Fed members are becoming a little bit...
What normally takes decades has been achieved in 12 months, without cutting corners.
Credit: Image: Karim Rafie “The findings provide an increased understanding of how the virus gets through the stomach and intestinal system. Continued research can provide answers...
Scientists and government sources claimed today that Johnson & Johnson’s single-jab COVID-19 vaccine could be given emergency use authorization as early as next month, according to...
After delaying its decision earlier this week, the EMA announced it has formally recommended authorizing Moderna’s Covid-19 vaccine
It may be two months before Moderna and the NIH can conclude whether they can halve their vaccine dose and provide the same level of protection
More than 3.1 billion doses have been ordered worldwide of the Oxford-AstraZeneca vaccine, providing a ray of hope in the fight against the pandemic.
UK First To Approve Astra-Zeneca Vaccine As "Tier 4" Lockdowns Expanded Even as regulators in the EU opt to give the approval process for the adenovirus-vector...